🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

CAMpania PugliA bRanch Iliaco

Recruitingn/aAges any - anyAllFederico II University
NCT06946381 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Spontaneus Multicentric Observational registry to investigate the medium and long-term performances of the Iliac E-liac Branch Device from Artivion for treatment of Aortoiliac aneurysms in a real-world consecutive patients cohort.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices Exclusion Criteria: * Patient's refusal to be enrolled in the registry * Patient treated with devices not including the E-liac stent-graft system
💊

What it tests

  • Evar
📍

Where

2 sites
Azienda ospedaliero-universitaria consorziale policlinico di Bari
Bari, Italy
Azienda Ospedaliera Universitaria Federico II
Naples, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy